Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson’s disease

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · see citing works

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Betarbet, R., Sherer, T., Mackenzie, G., Garcia-Osuna, M., Panov, A., & Greenamyre, J. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,797 · see citing works

Mechanisms Underlying Ubiquitination

Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,731 · see citing works

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481 · see citing works

α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 3,151 · see citing works

Impairment of the Ubiquitin-Proteasome System by Protein Aggregation

Bence, N., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,192 · see citing works

Aggresomes: A Cellular Response to Misfolded Proteins

Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148 · see citing works

A Drosophila model of Parkinson's disease

Feany, M., & Bender, W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,145 · see citing works

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · see citing works

Aggresomes, inclusion bodies and protein aggregation

Kopito, R. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01852-3 · Cited by 1,906 · see citing works

The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis

Voges, D., Zwickl, P., & Baumeister, W. P. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,894 · see citing works

Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative Disorders

Masliah, E., Rockenstein, E. M., Veinbergs, I., Mallory, M. E., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,763 · see citing works

Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System

Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722 · see citing works

The ubiquitin pathway in Parkinson's disease

Leroy, E., Boyer, R., Auburger, G. W. J., Leube, B., Ulm, G., Mezey, É., Harta, G., Brownstein, M., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,572 · see citing works

Neuropathology of Parkinson's Disease

Forno, L. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,556 · see citing works

Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy Lesions

Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,551 · see citing works

Alpha-synuclein and neurodegenerative diseases

Goedert, M. (2001) · Nature reviews. Neuroscience · doi:10.1038/35081564 · Cited by 1,402 · see citing works

ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE

Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,394 · see citing works

Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein

Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266 · see citing works

Chaperone Suppression of α-Synuclein Toxicity in a <i>Drosophila</i> Model for Parkinson's Disease

Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227 · see citing works

Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct

Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127 · see citing works

Ubiquitination of a new form of α-synuclein by parkin from human brain: implications for Parkinson's disease

Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K. S., & Selkoe, D. J. (2001) · Science · doi:10.1126/science.1060627 · Cited by 1,053 · see citing works

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin

Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., & Takahashi, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00407-x · Cited by 1,050 · see citing works

Cellular Defenses against Unfolded Proteins

Sherman, M. Y., & Goldberg, A. L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00177-5 · Cited by 984 · see citing works

Parkin functions as an E2-dependent ubiquitin– protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982 · see citing works

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.

Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981 · see citing works

Degradation of oxidized proteins by the 20S proteasome

Davies, K. J. A. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01250-0 · Cited by 849 · see citing works

Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease

Xu, J., Kao, S., Lee, F. J. S., Song, W., Jin, L., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 757 · see citing works

Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

Chung, K. K. K., Zhang, Y., Lim, K. L., Tanaka, Y., Huang, H., Gao, J., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2001) · Nature Medicine · doi:10.1038/nm1001-1144 · Cited by 750 · see citing works

Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System

Kirik, D., Rosenblad, C., Bürger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02780.2002 · Cited by 730 · see citing works

Understanding cell death in parkinson's disease

Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 686 · see citing works

Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease

Schapira, A. H. V., Mann, V. M., Cooper, J. A. D., Dexter, D. T., Daniel, S. E., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb05809.x · Cited by 673 · see citing works

Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease

Killiany, R., Gómez‐Isla, T., Moss, M. B., Kikinis, R., Sándor, T., Jolesz, F. A., Tanzi, R. E., Jones, K. J., Hyman, B. T., & Albert, M. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 659 · see citing works

Proteasomal function is impaired in substantia nigra in Parkinson’s disease

McNaught, K. S. P., & Jenner, P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01701-8 · Cited by 653 · see citing works

Accumulation of Mutant Huntingtin Fragments in Aggresome-like Inclusion Bodies as a Result of Insufficient Protein Degradation

Waelter, S., Boeddrich, A., Lurz, R., Scherzinger, E., Lüder, G., Lehrach, H. R., & Wanker, E. E. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1393 · Cited by 632 · see citing works

Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr α‐synuclein mutation

Spira, P. J., Sharpe, D. M., Halliday, G. M., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 628 · see citing works

A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis

Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598 · see citing works

Altered proteasomal function in sporadic Parkinson’s disease

St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573 · see citing works

Expression of A53T Mutant But Not Wild-Type α-Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death

Stefanis, L., Larsen, K. E., Rideout, H. J., Sulzer, D. L., & Greene, L. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09549.2001 · Cited by 569 · see citing works

A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body Disease

Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P. G., & Halliwell, B. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547 · see citing works

Protein Nitration in Parkinsonʼs Disease

Good, P. F., Hsu, A., Werner, P., Perl, D. P., & Olanow, C. W. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00006 · Cited by 540 · see citing works

Failure of the ubiquitin-proteasome system in Parkinson’s disease

McNaught, K. S. P., Olanow, C. W., Halliwell, B., Isacson, O., & Jenner, P. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086067 · Cited by 519 · see citing works

Dynamic Association of Proteasomal Machinery with the Centrosome

Wigley, W. C., Fabunmi, R. P., Lee, M. G., Marino, C. R., Muallem, S., Demartino, G., & Thomas, P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.3.481 · Cited by 513 · see citing works

Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.

Cummings, C., Reinstein, E., Sun, Y., Antalffy, B. A., Jiang, Y.-H., Ciechanover, A., Orr, H., Beaudet, A., & Zoghbi, H. (1999) · Neuron · doi:10.1016/s0896-6273(00)81035-1 · Cited by 513 · see citing works

Ester Bond-containing Tea Polyphenols Potently Inhibit Proteasome Activity in Vitro and in Vivo

Nam, S., Smith, D. M., & Dou, Q. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004209200 · Cited by 509 · see citing works

Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice

Saigoh, K., Wang, Y., Suh, J., Yamanishi, T., Sakai, Y., Kiyosawa, H., Harada, T., Ichihara, N., Wakana, S., Kikuchi, T., et al. (1999) · Nature Genetics · doi:10.1038/12647 · Cited by 501 · see citing works

Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis

Tanaka, Y. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.919 · Cited by 497 · see citing works

Lewy bodies and parkinsonism in families with parkin mutations

Farrer, M. J., Chan, P., Chen, R., Tan, L. C. S., Lincoln, S., Hernandez, D. G., Forno, L. S., Gwinn, K. A., Petrucelli, L., Hussey, J., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1132 · Cited by 483 · see citing works

A large kindred with autosomal dominant Parkinson's disease

Golbe, L., Iorio, G. D., Bonavita, V., Miller, D. C., & Duvoisin, R. (1990) · Annals of Neurology · doi:10.1002/ana.410270309 · Cited by 463 · see citing works

Increased Protein Oxidation in Human Substantia Nigra Pars Compacta in Comparison with Basal Ganglia and Prefrontal Cortex Measured with an Improved Dinitrophenylhydrazine Assay

Floor, E., & Wetzel, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010268.x · Cited by 452 · see citing works

Induction of α-Synuclein Aggregation by Intracellular Nitrative Insult

Paxinou, E., Chen, Q., Weisse, M., Giasson, B. I., Norris, E. H., Rueter, S. M., Trojanowski, J. Q., Lee, V. M. ‐., & Ischiropoulos, H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08053.2001 · Cited by 440 · see citing works

Degradation of α-Synuclein by Proteasome

Bennett, M. C., Bishop, J. F., Leng, Y., Chock, P. B., Chase, T. N., & Mouradian, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33855 · Cited by 417 · see citing works

Pathology and Biology of the Lewy Body

Pollanen, M. S., Dickson, D. W., & Bergeron, C. (1993) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199305000-00001 · Cited by 396 · see citing works

Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q

Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K., & Mizuno, Y. (1998) · Neurology · doi:10.1212/wnl.51.3.890 · Cited by 370 · see citing works

α‐Synuclein metabolism and aggregation is linked to ubiquitin‐independent degradation by the proteasome

Tofaris, G. K., Layfield, R., & Spillantini, M. G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03115-5 · Cited by 363 · see citing works

Ubiquitin carboxyl‐terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases

Lowe, J. S., McDermott, H., Landon, M., Mayer, R. J., & Wilkinson, K. D. (1990) · The Journal of Pathology · doi:10.1002/path.1711610210 · Cited by 359 · see citing works

Oxidative Modification and Inactivation of the Proteasome during Coronary Occlusion/Reperfusion

Bulteau, A., Lundberg, K. C., Humphries, K. M., Sadek, H. A., Szweda, P. A., Friguet, B., & Szweda, L. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100142200 · Cited by 354 · see citing works

Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation.

Spira, P. J., Sharpe, D. M., Halliday, G. M., Cavanagh, J., & Nicholson, G. A. (2001) · PubMed · Cited by 343 · see citing works

Degradation of Oxidized Proteins in K562 Human Hematopoietic Cells by Proteasome

Grune, T., Reinheckel, T., & Davies, K. J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15504 · Cited by 328 · see citing works

Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation

Ma, J., & Lindquist, S. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011578098 · Cited by 295 · see citing works

Immunohistochemical and subcellular localization of parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients

Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5 · Cited by 282 · see citing works

Lack of Nigral Pathology in Transgenic Mice Expressing Human α-Synuclein Driven by the Tyrosine Hydroxylase Promoter

Matsuoka, Y., Vila, M., Lincoln, S., McCormack, A., Picciano, M., LaFrancois, J., Yu, X., Dickson, D., Langston, W. J., McGowan, E., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0392 · Cited by 281 · see citing works

Aggresome‐related biogenesis of Lewy bodies

McNaught, K. S. P., Shashidharan, P., Perl, D. P., Jenner, P. G., & Olanow, C. W. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02301.x · Cited by 277 · see citing works

Proteasome inhibition causes nigral degeneration with inclusion bodies in rats

McNaught, K. S. P., rklund, L. M. B., Belizaire, R., Ole Isacson, A., Jenner, P. G., & Olanow, C. W. (2002) · Neuroreport · doi:10.1097/00001756-200208070-00018 · Cited by 275 · see citing works

Proteasomal inhibition leads to formation of ubiquitin/α‐synuclein‐immunoreactive inclusions in PC12 cells

Rideout, H. J., Larsen, K. E., Sulzer, D. L., & Stefanis, L. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00474.x · Cited by 274 · see citing works

Concurrence of α-synuclein and tau brain pathology in the Contursi kindred

Duda, J. E., Giasson, B. I., Mabon, M. E., Miller, D. C., Golbe, L. I., Lee, V. M. ‐., & Trojanowski, J. Q. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0563-3 · Cited by 274 · see citing works

α-Synuclein–enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons

McLean, P. J., Kawamata, H., & Hyman, B. T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00113-0 · Cited by 236 · see citing works

Effect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insult

Lee, M., Hyun, D., Halliwell, B. B., & Jenner, P. G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00149.x · Cited by 232 · see citing works

Chaperone‐like activity of synucleins

Souza, J. M., Giasson, B. I., Lee, V. M. ‐., & Ischiropoulos, H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01563-5 · Cited by 221 · see citing works

Immunocytochemical Co-localization of the Proteasome in Ubiquitinated Structures in Neurodegenerative Diseases and the Elderly

Ii, K., Ito, H., Tanaka, K., & Hirano, A. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199702000-00002 · Cited by 215 · see citing works

Dopaminergic Cell Loss Induced by Human A30P α -Synuclein Gene Transfer to the Rat Substantia Nigra

Klein, R. L., King, M. A., Hamby, M. E., & Meyer, E. M. (2002) · Human Gene Therapy · doi:10.1089/10430340252837206 · Cited by 209 · see citing works

Regulated trafficking of neurotransmitter transporters: common notes but different melodies

Robinson, M. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00698.x · Cited by 204 · see citing works

Neuronal vulnerability in Parkinson’s disease

Hirsch, É. C., Faucheux, B. A., Damier, P., Prigent, A., & Agid, Y. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6842-4_9 · Cited by 192 · see citing works

Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with β-tubulin: relevance to Huntington's disease

Hoffner, G., Kahlem, P., & Djian, P. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.5.941 · Cited by 182 · see citing works

Effect of Wild-type or Mutant Parkin on Oxidative Damage, Nitric Oxide, Antioxidant Defenses, and the Proteasome

Hyun, D.-H., Lee, M., Hattori, N., Kubo, S.-I., Mizuno, Y., Halliwell, B., & Jenner, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200666200 · Cited by 172 · see citing works

Effects of Pharmacological Agents upon a Transgenic Model of Parkinson’s Disease in Drosophila melanogaster

Pendleton, R. G., Parvez, F., SAYED, M. E. S., & Hillman, R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.91 · Cited by 158 · see citing works

Mutation analysis and association studies of the UCHL1 gene in German Parkinsonʼs disease patients

Wintermeyer, P., Krüger, R., Kuhn, W., Müller, T. H., Woitalla, D., Berg, D., Becker, G., Leroy, E., Polymeropoulos, M. H., Berger, K., et al. (2000) · Neuroreport · doi:10.1097/00001756-200007140-00004 · Cited by 141 · see citing works

Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases

Wilkinson, K. D., Deshpande, S. S., & Larsen, C. N. (1992) · Biochemical Society Transactions · doi:10.1042/bst0200631 · Cited by 132 · see citing works

Genetics of Parkinson's disease

Gasser, T. (2001) · Journal of Neurology · doi:10.1007/s004150170066 · Cited by 124 · see citing works

Parkin and Parkinsonʼs disease

Mizuno, Y., Hattori, N., Mori, H., Suzuki, T., & Tanaka, K. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00008 · Cited by 123 · see citing works

THE PHYSIOLOGICAL RELATION OF PLANT CAROTINOIDS TO THE CAROTINOIDS OF THE COW, HORSE, SHEEP, GOAT, PIG, AND HEN

Palmer, L. S. (1916) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86887-9 · Cited by 119 · see citing works

Genetics of Parkinson's disease.

Gasser, T. (2004) · Europe PMC (PubMed Central) · Cited by 111 · see citing works

TorsinA accumulation in Lewy bodies in sporadic Parkinson’s disease

Shashidharan, P., Good, P. F., Hsu, A., Perl, D. P., Brin, M. F., & Olanow, C. W. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02702-5 · Cited by 105 · see citing works

Rat α‐Synuclein Interacts with Tat Binding Protein 1, a Component of the 26S Proteasomal Complex

Ghee, M., Fournier, A., & Mallet, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752221.x · Cited by 95 · see citing works

Caretaker or undertaker? The role of the proteasome in aging

Gaczynska, M. E., Osmulski, P. A., & Ward, W. F. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00246-3 · Cited by 83 · see citing works

Aggresome Formation in Liver Cells in Response to Different Toxic Mechanisms: Role of the Ubiquitin-Proteasome Pathway and the Frameshift Mutant of Ubiquitin

French, B. A., van Leeuwen, F. W., Riley, N. E., Yuan, Q. X., Bardag‐Gorce, F., Gaal, K. K., Lue, Y., Marceau, N., & French, S. W. (2001) · Experimental and Molecular Pathology · doi:10.1006/exmp.2001.2401 · Cited by 77 · see citing works

Association between a polymorphism of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene and sporadic Parkinson's disease

Zhang, J., Hattori, N., Leroy, E., Morris, H. R., Kubo, S., Kobayashi, T., Wood, N. W., Polymeropoulos, M. H., & Mizuno, Y. (2000) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00015-8 · Cited by 68 · see citing works

The expression of mRNAs for the proteasome complex is developmentally regulated in the rat mesencephalon

El‐Khodor, B. F., Kholodilov, N. G., Yarygina, O., & Burke, R. E. (2001) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00181-x · Cited by 38 · see citing works

The parkin gene and its phenotype

Bonifati, V., Michele, G. D., L�cking, C. B., D�rr, A., Fabrizio, E., Ambrosio, G., Vanacore, N., Mari, M. D., Marconi, R., Capus, L., et al. (2001) · Neurological Sciences · doi:10.1007/s100720170042 · Cited by 35 · see citing works

Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson’s disease patients are consistent with protein aggregation

Lopiano, L., Fasano, M., Giraudo, S., Digilio, G., Koenig, S. H., Torre, E., Bergamasco, B., & Aime, S. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00036-x · Cited by 30 · see citing works

Occurrence of glutamate receptor subunit 1–containing aggresome‐like structures during normal development of rat spinal cord interneurons

Serrando, M., Casanovas, A., & Esquerda, J. E. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1419 · Cited by 16 · see citing works

Untitled work

Solano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3 · see citing works

Untitled work

Mattson, M. (1999) · doi:10.1002/(sici)1097-4547(19991001)58:1

Molecular Pathways of Neurodegeneration in Parkinson's Disease

Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,659 · see citing works

Epidemiology and etiology of Parkinson's disease: a review of the evidence

Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199 · see citing works

The Ubiquitin Proteasome System in Neurodegenerative Diseases

Ciechanover, A. J., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 984 · see citing works

Oxidative Stress and Neurotoxicity

Sayre, L. M., Perry, G. L., & Smith, M. A. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 868 · see citing works

Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder

Alexander, G. E. (2004) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2004.6.3/galexander · Cited by 522 · see citing works

Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

Hald, A., & Lotharius, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.013 · Cited by 506 · see citing works

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

McNaught, K. S. P., Perl, D. P., Brownell, A., & Olanow, C. W. (2004) · Annals of Neurology · doi:10.1002/ana.20186 · Cited by 548 · see citing works

The pathogenesis of cell death in Parkinson's disease

Jenner, P. G., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s24 · Cited by 449 · see citing works

Lewy-body formation is an aggresome-related process: a hypothesis

Olanow, C. W., Perl, D. P., Demartino, G., & McNaught, K. S. P. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00827-0 · Cited by 304 · see citing works

Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement

Schipper, H. M., Song, W., Zukor, H., Hascalovici, J. R., & Zeligman, D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06160.x · Cited by 298 · see citing works

Neuroprotection in Parkinson Disease

Schapira, A. H. V., & Olanow, C. W. (2004) · JAMA · doi:10.1001/jama.291.3.358 · Cited by 290 · see citing works

Familial Parkinson's Disease-associated L166P Mutation Disrupts DJ-1 Protein Folding and Function

Olzmann, J. A., Brown, K., Wilkinson, K. D., Rees, H. D., Huai, Q., Ke, H., Levey, A. I., Li, L., & Chin, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311017200 · Cited by 266 · see citing works

Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease

Dev, K. K. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00140-0 · Cited by 262 · see citing works

UCHL1 is a Parkinson's disease susceptibility gene

Maraganore, D. M., Lesnick, T. G., Elbaz, A., Chartier‐Harlin, M., Gasser, T., Krüger, R., Hattori, N., Mellick, G. D., Quattrone, A., Satoh, J., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20017 · Cited by 263 · see citing works

Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms

Zhang‐James, Y., James, M., Middleton, F. A., & Davis, R. L. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30195 · Cited by 261 · see citing works

Use of antihypertensives and the risk of Parkinson disease

Becker, C., Jick, S. S., & Meier, C. R. (2008) · Neurology · doi:10.1212/01.wnl.0000303818.38960.44 · Cited by 230 · see citing works

Parkinson's disease: The syndrome, the pathogenesis and pathophysiology

Bartels, A. L., & Leenders, K. L. (2008) · Cortex · doi:10.1016/j.cortex.2008.11.010 · Cited by 225 · see citing works

A missense mutation (L166P) in DJ‐1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo‐oligomerization

Moore, D. J., Zhang, L., Dawson, T. M., & Dawson, V. L. (2003) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2003.02265.x · Cited by 222 · see citing works

Ubiquitin–proteasome system and Parkinson's disease

Olanow, C. W., & McNaught, K. S. P. (2006) · Movement Disorders · doi:10.1002/mds.21013 · Cited by 213 · see citing works

A Wnt1 regulated Frizzled-1/β-Cateninsignaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection

L’Episcopo, F., Serapide, M. F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Pluchino, S., & Marchetti, B. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-49 · Cited by 196 · see citing works

Clinical Features of Parkinson’s Disease: The Evolution of Critical Symptoms

Váradi, C. (2020) · Biology · doi:10.3390/biology9050103 · Cited by 196 · see citing works

Safinamide

Caccia, C., Maj, R., Calabresi, M., Maestroni, S., Faravelli, L., Curatolo, L. M., Salvati, P., & Fariello, R. G. (2006) · Neurology · doi:10.1212/wnl.67.7_suppl_2.s18 · Cited by 195 · see citing works

Mitochondrial Dysfunction in Parkinson's Disease

Keane, P. C., Kurzawa‐Akanbi, M., Blain, P. G., & Morris, C. M. (2011) · Parkinson s Disease · doi:10.4061/2011/716871 · Cited by 177 · see citing works

Neuronal intranuclear hyaline inclusion disease

Takahashi‐Fujigasaki, J. (2003) · Neuropathology · doi:10.1046/j.1440-1789.2003.00524.x · Cited by 168 · see citing works

Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease

McNaught, K. S. P., & Olanow, C. W. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.012 · Cited by 165 · see citing works

Microglial PHOX and Mac‐1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha‐synuclein

Zhang, W., Dallas, S., Zhang, D., Guo, J., Pang, H., Wilson, B. C., Miller, D. S., Chen, B., Zhang, W., McGeer, P. L., et al. (2007) · Glia · doi:10.1002/glia.20532 · Cited by 161 · see citing works

Inhibitory effects of pesticides on proteasome activity: Implication in Parkinson's disease

Wang, X., Li, S., Chou, A. P., & Bronstein, J. M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.012 · Cited by 158 · see citing works

Evaluation of animal models of Parkinson's disease for neuroprotective strategies

Emborg, M. E. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.08.004 · Cited by 156 · see citing works

Hsp70 Gene Transfer by Adeno-associated Virus Inhibits MPTP-Induced Nigrostriatal Degeneration in the Mouse Model of Parkinson Disease

Dong, Z., Wolfer, D. P., Lipp, H., & Büeler, H. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.007 · Cited by 148 · see citing works

The Neuroprotective Effect of Dimethyl Fumarate in an MPTP-Mouse Model of Parkinson's Disease: Involvement of Reactive Oxygen Species/Nuclear Factor-κB/Nuclear Transcription Factor Related to NF-E2

Campolo, M., Casili, G., Biundo, F., Crupi, R., Cordaro, M., Cuzzocrea, S., & Esposito, E. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6800 · Cited by 144 · see citing works

The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes

Macedo, M. G. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg304 · Cited by 144 · see citing works

Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder

Khan, A. U., Akram, M., Daniyal, M., & Zainab, R. (2018) · International Journal of Neuroscience · doi:10.1080/00207454.2018.1486837 · Cited by 145 · see citing works

Metal ions and oxidative protein modification in neurological disease.

Sayre, L. M., Moreira, P. I., Smith, M. A., & Perry, G. L. (2005) · PubMed · Cited by 135 · see citing works

Proteasome Inhibition Induces Glutathione Synthesis and Protects Cells from Oxidative Stress

Yamamoto, N., Sawada, H., Izumi, Y., Kume, T., Katsuki, H., Shimohama, S., & Akaike, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603712200 · Cited by 133 · see citing works

How does parkin ligate ubiquitin to Parkinson's disease?

Kahle, P. J., & Haass, C. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400188 · Cited by 131 · see citing works

Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: Relevance to parkinson′s disease

Zhou, Y. F., Shie, F., Piccardo, P., Montine, T. J., & Zhang, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.048 · Cited by 132 · see citing works

UCH‐L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease

Ardley, H. C., Scott, G. B., Rose, S. A., Tan, N. G. S., & Robinson, P. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02485.x · Cited by 127 · see citing works

14‐3‐3η is a novel regulator of parkin ubiquitin ligase

Sato, S., Chiba, T., Sakata, E., Kato, K., Mizuno, Y., Hattori, N., & Tanaka, K. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600774 · Cited by 126 · see citing works

Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1

Dong, Z., Ferger, B., Paterna, J., Vogel, D., Furler, S., Osinde, M., Feldon, J., & Büeler, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2132992100 · Cited by 123 · see citing works

Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies

Trimmer, P. A., Borland, M., Keeney, P. M., Bennett, J. P., & Parker, W. D. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02168.x · Cited by 121 · see citing works

A Potential Role for Cyclized Quinones Derived from Dopamine, DOPA, and 3,4-Dihydroxyphenylacetic Acid in Proteasomal Inhibition

Zafar, K. S., Siegel, D. M., & Ross, D. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024703 · Cited by 120 · see citing works

Ubiquitin, proteasome and parkin

Tanaka, K., Suzuki, T., Hattori, N., & Mizuno, Y. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.026 · Cited by 119 · see citing works

Metal-catalyzed Oxidation of α-Synuclein

Cole, N. B., Murphy, D. D., Lebowitz, J., Noto, L. D., Levine, R. L., & Nussbaum, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409946200 · Cited by 117 · see citing works

Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity

Bal‐Price, A., & Meek, M. E. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.006 · Cited by 116 · see citing works

Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models

Sun, F., Anantharam, V., Zhang, D., Latchoumycandane, C., Kanthasamy, A., & Kanthasamy, A. G. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.06.006 · Cited by 107 · see citing works

Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults

Liu, F., Hindupur, J., Nguyen, J. L., Ruf, K. J., Zhu, J., Schieler, J. L., Bonham, C. C., Wood, K. V., Davisson, V. J., & Rochet, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.022 · Cited by 102 · see citing works

Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons

Herrera, A. J., Tomás‐Camardiel, M., Venero, J. L., Cano, J., & Machado, A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0121-3 · Cited by 103 · see citing works

Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits

Beach, T. G., Sue, L. I., Walker, D. G., Lue, L. F., Connor, D. J., Caviness, J. N., Sabbagh, M. N., & Adler, C. H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0250-5 · Cited by 101 · see citing works

Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro‐apoptotic transcriptional responses: a microarray analysis

Yew, E. H. J., Cheung, N. S., Choy, M. S., Qi, R. Z., Lee, A. Y. W., Peng, Z. F., Melendez, A. J., Manikandan, J., Koay, E. S. C., Chiu, L.-L., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03220.x · Cited by 96 · see citing works

Proteasomal Expression, Induction of Immunoproteasome Subunits, and Local MHC Class I Presentation in Myofibrillar Myopathy and Inclusion Body Myositis

Ferrer, I., Martín, B., Castaño, J. G., Lucas, J. J., Moreno, D., & Olivé, M. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.5.484 · Cited by 95 · see citing works

Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation

Kim, Y. M., Jang, W. H., Quezado, M., Oh, Y., Chung, K. C., Junn, E., & Mouradian, M. M. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.015 · Cited by 90 · see citing works

Proteasome dysfunction in aged human α-synuclein transgenic mice

Chen, L., Thiruchelvam, M. J., Madura, K., & Richfield, E. K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.004 · Cited by 88 · see citing works

Differential Effects of Parkinson's Disease-associated Mutations on Stability and Folding of DJ-1

Görner, K., Holtorf, E., Odoy, S., Nuscher, B., Yamamoto, A., Regula, J. T., Beyer, K., Haass, C., & Kahle, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309204200 · Cited by 87 · see citing works

Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease

Ahlskog, J. E. (2004) · Movement Disorders · doi:10.1002/mds.20362 · Cited by 83 · see citing works

Genetic and Environmental Factors Influencing Glutathione Homeostasis inSaccharomyces cerevisiae

Perrone, G. G., Grant, C. M., & Dawes, I. W. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0560 · Cited by 83 · see citing works

Parkin Directly Modulates 26S Proteasome Activity

Um, J. W., Im, E., Lee, H. J., Min, B., Yoo, L., Yoo, J., Lübbert, H., Stichel-Gunkel, C. C., Cho, H.-S., Yoon, J. B., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2862-09.2010 · Cited by 81 · see citing works

Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson’s Disease

Sala, G., Marinig, D., Arosio, A., & Ferrarese, C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00157 · Cited by 81 · see citing works

An expert opinion on safinamide in Parkinson's disease

ONOFRJ, M. C., Bonanni, L., & Thomas, A. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.7.1115 · Cited by 80 · see citing works

Neurons Expressing the Highest Levels of γ-Synuclein Are Unaffected by Targeted Inactivation of the Gene

Ninkina, N., Papachroni, K., Robertson, D. C., Schmidt, O., Delaney, L., O'Neill, F., Court, F., Rosenthal, A., Fleetwood-Walker, S. M., Davies, A. M., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8233-8245.2003 · Cited by 75 · see citing works

Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism.

Asanuma, M., Miyazaki, I., Diaz-Corrales, F. J. J., & Ogawa, N. (2004) · PubMed · doi:10.18926/amo/32105 · Cited by 76 · see citing works

Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition

Miwa, H., Kubo, T., Suzuki, A., Nishi, K., & Kondo, T. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.01.024 · Cited by 76 · see citing works

Proteasomal dysfunction in sporadic Parkinson's disease

McNaught, K. S. P., Jackson, T., JnoBaptiste, R., Kapustin, A., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s37 · Cited by 73 · see citing works

Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia

Kawahata, I., & Fukunaga, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113779 · Cited by 71 · see citing works

Paraquat and Parkinson’s disease: a systematic review protocol according to the OHAT approach for hazard identification

Vaccari, C., Dib, R. E., & de Camargo, J. L. V. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0491-x · Cited by 72 · see citing works

Quinone-induced protein handling changes: Implications for major protein handling systems in quinone-mediated toxicity

Xiong, R., Siegel, D. M., & Ross, D. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.08.014 · Cited by 71 · see citing works

Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies

Barrachina, M., Castaño, E., Dalfó, E., Maes, T., Buesa, C., & Ferrer, I. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.005 · Cited by 69 · see citing works

Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome

Shamoto‐Nagai, M., Maruyama, W., Yi, H. L., Akao, Y., Tribl, F., Gerlach, M., Osawa, T., Riederer, P. F., & Naoi, M. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0410-5 · Cited by 67 · see citing works

Substantia Nigra Marinesco Bodies Are Associated with Decreased Striatal Expression of Dopaminergic Markers

Beach, T. G., Walker, D. G., Sue, L. I., Newell, A., Adler, C., & Joyce, J. N. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.329 · Cited by 66 · see citing works

Levels of brain related proteins in cerebrospinal fluid: An aid in the differential diagnosis of parkinsonian disorders

Constantinescu, R., Zetterberg, H., Holmberg, B., & Rosengren, L. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.001 · Cited by 65 · see citing works

The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease

Bae, N.-Y., Ahn, T.-W., Chung, S., Oh, M. S., Ko, H., Oh, H., Park, G., & Yang, H. O. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.12.016 · Cited by 64 · see citing works

Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits

Zhang, J., Stanton, D. M., Nguyen, X. V., Liu, M., Zhang, Z., Gash, D. M., & Bing, G. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.049 · Cited by 64 · see citing works

Neuroprotective Effect of Rosmarinus officinalis Extract on Human Dopaminergic Cell line, SH-SY5Y

Park, S., Kim, S., Sapkota, K., & Kim, S.-J. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-010-9502-3 · Cited by 63 · see citing works

Iron Chelators as Potential Therapeutic Agents for Parkinsons Disease

Perez, C., Tong, Y., & Guo, M. (2008) · Current Bioactive Compounds · doi:10.2174/157340708786305952 · Cited by 62 · see citing works

Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis-targeted, disease-modifying strategy

Olanow, C. W., & Jankovic, J. J. (2005) · Movement Disorders · doi:10.1002/mds.20457 · Cited by 61 · see citing works

Proteomic Profiling of Neuromas Reveals Alterations in Protein Composition and Local Protein Synthesis in Hyper-Excitable Nerves

Huang, H., Cendán, C. M., Roza, C., Okuse, K., Cramer, R., Timms, J. F., & Wood, J. N. (2008) · Molecular Pain · doi:10.1186/1744-8069-4-33 · Cited by 60 · see citing works

Differential protein expression of hippocampal cells associated with heavy metals (Pb, As, and MeHg) neurotoxicity: Deepening into the molecular mechanism of neurodegenerative diseases

Karri, V., Ramos, D., Bauzá‐Martinez, J., Odena, M. A., de Oliveira, E., Coort, S. L., Evelo, C. T., Mariman, E. C. M., Schuhmacher, M., & Kumar, V. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.06.020 · Cited by 63 · see citing works

Role for the Ubiquitin-Proteasome System in Parkinson's Disease and Other Neurodegenerative Brain Amyloidoses

Moore, D. J., Dawson, V. L., & Dawson, T. M. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:95 · Cited by 59 · see citing works

Retinoic acid protects against proteasome inhibition associated cell death in SH-SY5Y cells via the AKT pathway

Cheng, B., Martinez, A. A., Morado, J., Scofield, V. L., Roberts, J. L., & Maffi, S. K. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.10.014 · Cited by 57 · see citing works

Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: Implications for Parkinson's disease

Choi, H. J., Lee, S. Y., Cho, Y., No, H., Kim, S. W., & Hwang, O. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.10.011 · Cited by 58 · see citing works

Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target

Behl, T., Madaan, P., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Al‐Harrasi, A., Chigurupati, S., Alrashdi, I., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810161 · Cited by 56 · see citing works

The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein—implications for Parkinson's disease.

Marx, F. P., Soehn, A. S., Berg, D., Melle, C., Schiesling, C., Lang, M., Kautzmann, S., Strauss, K. M., Franck, T., Engelender, S., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-6734com · Cited by 52 · see citing works

Loss of dopaminergic neurons by the induction of inducible nitric oxide synthase and cyclooxygenase‐2 via CD40: Relevance to Parkinson's disease

Okuno, T., Nakatsuji, Y., Kumanogoh, A., Moriya, M., Ichinose, H., Sumi, H., Fujimura, H., Kikutani, H., & Sakoda, S. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20599 · Cited by 54 · see citing works

Increased telomerase improves motor function and alpha-synuclein pathology in a transgenic mouse model of Parkinson’s disease associated with enhanced autophagy

Wan, T., Weir, E. J., Johnson, M., Korolchuk, V. I., & Saretzki, G. C. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101953 · Cited by 52 · see citing works

Disease-modifying drugs and Parkinson's disease

Allain, H., Bentué‐Ferrer, D., & Akwa, Y. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.003 · Cited by 52 · see citing works

Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice

Ballok, D. A., Earls, A. M., Krasnik, C. E., Hoffman, S. A., & Šakić, B. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.04.003 · Cited by 51 · see citing works

Proteasome inhibitor‐induced apoptosis is mediated by positive feedback amplification of PKCδ proteolytic activation and mitochondrial translocation

Sun, F., Kanthasamy, A., Song, C., Yang, Y., Anantharam, V., & Kanthasamy, A. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00293.x · Cited by 50 · see citing works

Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease

Schapira, A. H. V., & Olanow, C. W. (2003) · Annals of Neurology · doi:10.1002/ana.10514 · Cited by 50 · see citing works

Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra

Moran, L. B., Croisier, E., Duke, D. C., Kalaitzakis, M. E., Roncaroli, F., Deprez, M., Dexter, D. T., Pearce, R. K. B., & Graeber, M. B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0181-6 · Cited by 50 · see citing works

Rosmarinic acid protects against MPTP-induced toxicity and inhibits iron-induced α-synuclein aggregation

Qu, L., Xu, H., Jia, W., Jiang, H. F., & Xie, J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.042 · Cited by 47 · see citing works

Parkinsons Disease: Genetics and Beyond

Inamdar, N., Arulmozhi, D. K., Tandon, A., & Bodhankar, S. L. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866893 · Cited by 44 · see citing works

Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition

Bandopadhyay, R., Kingsbury, A. E., Muqit, M. M. K., Harvey, K., Reid, A. R., Kilford, L., Engelender, S., Schlossmacher, M. G., Wood, N. W., Latchman, D. S., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.021 · Cited by 44 · see citing works

Insulin-like growth factor-I mediates neuroprotection in proteasome inhibition-induced cytotoxicity in SH-SY5Y cells

Cheng, B., Maffi, S. K., Martinez, A. A., Acosta, Y. P. V., Morales, L. D., & Roberts, J. L. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.04.002 · Cited by 43 · see citing works

Proteomic profiling of cerebrospinal fluid in parkinsonian disorders

Constantinescu, R., Andréasson, U., Li, S., Podust, V. N., Mattsson, N., Anckarsäter, R., Anckarsäter, H. S., Rosengren, L., Holmberg, B., Blennow, K., et al. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.06.011 · Cited by 43 · see citing works

The innate and adaptive immunological aspects in neurodegenerative diseases

Rodrigues, M. C. O., Sanberg, P. R., Cruz, L. E. G., & Garbuzova-Davis, S. N. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.020 · Cited by 41 · see citing works

Mitochondria and ubiquitin-proteasomal system interplay: Relevance to Parkinson's disease

Domingues, A. F., Arduíno, D. M., Esteves, A. R., Swerdlow, R. H., Oliveira, C. R., & Cardoso, S. M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.06.007 · Cited by 39 · see citing works

Effect of Curcumin on Protein Damage Induced by Rotenone in Dopaminergic PC12 Cells

Buratta, S., Chiaradia, E., Tognoloni, A., Gambelunghe, A., Meschini, C., Palmieri, L., Muzi, G., Urbanelli, L., Emiliani, C., & Tancini, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082761 · Cited by 38 · see citing works

A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132

Zafar, K. S., Inayat‐Hussain, S. H., & Ross, D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04637.x · Cited by 38 · see citing works

MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome

Zeng, B. ‐., Iravani, M. M., Lin, S., Irifune, M., Kuoppamäki, M., Al‐Barghouthy, G., Smith, L., Jackson, M. J., Rose, S., Medhurst, A. D., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04718.x · Cited by 38 · see citing works

Inflammation in parkinson’s disease

Hald, A., van Beek, J., & Lotharius, J. (2007) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/1-4020-5688-5_12 · Cited by 37 · see citing works

L-DOPA treatment from the viewpoint of neuroprotection

Ogawa, N., Asanuma, M., Miyazaki, I., Diaz-Corrales, F. J. J., & Miyoshi, K. (2005) · Journal of Neurology · doi:10.1007/s00415-005-4006-7 · Cited by 36 · see citing works

Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease

McNaught, K. S. P., & Olanow, C. W. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.012 · Cited by 165 · see citing works

Ubiquitin–proteasome system and Parkinson's diseases

Betarbet, R. S., Sherer, T., & Greenamyre, J. T. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.021 · Cited by 245 · see citing works

Altered proteasomal function in sporadic Parkinson’s disease

St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573 · see citing works

Role of the ubiquitin proteasome system in Parkinson's disease

Ping, N. (2010) · Jiepou kexue jinzhan

Ubiquitin–proteasome system and Parkinson's disease

Olanow, C. W., & McNaught, K. S. P. (2006) · Movement Disorders · doi:10.1002/mds.21013 · Cited by 213 · see citing works